Video

ASCRS Live: First in-human results for the OmniVu IOL system

George Waring IV, MD met with the onsite Ophthalmology Times© team to share data from his presentation on the first in-human results for the OmniVu IOL system.

George Waring IV, MD met with the onsite Ophthalmology Times© team to share data from his presentation on the first in-human results for the OmniVu IOL system.

Video transcript

Editor’s note: Transcript lightly edited for clarity.

George Waring IV, MD:

Hi, it's George Waring from the Waring Vision Institute in Mount Pleasant, South Carolina, and I'm here at the American Society of Cataract and Refractive Surgery in San Diego where I had the distinct honor of presenting the first in-human results for the OmniVu IOL system.


The OmniVu IOL system is a modular shape-changing IOL by Atia Vision designed to provide a full range of functional vision while preserving visual quality. The IOL system was designed with other accommodative technologies, historical technologies, and all the learning lessons that we've gathered over the years. So the results were as follows: 20/32 visual acuity over 2.75 diopters of defocus monocularly and then extended out to 4 diopters when measured binocularly. One hunded percent of patients achieved 20/20 or greater distance corrected visual acuity and intermediate visual acuity and 20/32 or better near visual acuity.


We couldn't be more excited about this. The results were stable over 6 months. and I think this is just really promising technology for what may represent a new chapter in presbyopia correction and presbyopia IOLs. Thank you very much.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.